Emmanuel Katsanis (E Katsanis)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 26

Top Topics

Prognostic Factors

Acute Lymphoblastic Leukemia

Top Venues

Cancer research communications

Bone marrow transplantation

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Dimitrios Filioglou, Laurel Truscott, Naresh Reddivalla, Emmanuel Katsanis
Outcomes of haploidentical bone marrow transplantation in infant acute leukemia: a single center experience. Bone marrow transplantation (2024)
Forrest L Baker, Kyle A Smith, Preteesh L Mylabathula, Tiffany M Zúñiga, Douglass M Diak, Helena Angelica Pereira Batatinha, Grace M Niemiro, Michael David Seckeler, Charles R Pedlar, Daniel P O'Connor, Jamie N Colombo, Emmanuel Katsanis, Richard J Simpson
Exercise-induced β2-adrenergic receptor activation enhances the anti-leukemic activity of expanded γδ T-Cells via DNAM-1 upregulation and PVR/Nectin-2 recognition. Cancer research communications (2024)
Forrest L Baker, Kyle A Smith, Preteesh L Mylabathula, Tiffany M Zúñiga, Douglass M Diak, Helena Angelica Pereira Batatinha, Grace M Niemiro, Michael David Seckeler, Charles R Pedlar, Daniel P O'Connor, Jamie N Colombo, Emmanuel Katsanis, Richard J Simpson
Exercise-induced β2-adrenergic receptor activation enhances the anti-leukemic activity of expanded γδ T-Cells via DNAM-1 upregulation and PVR/Nectin-2 recognition. Cancer research communications (2024)
Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Anant Vatsayan, Julie-An Talano, Christina Baggott, Deborah E Schiff, Emmanuel Katsanis, Arunkumar J Modi, Troy C Quigg, Sunil S Raikar, Liora M Schultz, Lauren Pommert
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood advances 8 (15) (2024)
Dimitrios Filioglou, Laurel Truscott, Naresh Reddivalla, Emmanuel Katsanis
Outcomes of haploidentical bone marrow transplantation in infant acute leukemia: a single center experience. Bone marrow transplantation 59 (7) (2024)
Megan J Cracchiolo, Lisa Davis, Andrew P Matiatos, Dan W Davini, Muhammad Husnain, Richard J Simpson, Vasilios Voudouris, Emmanuel Katsanis
Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies. Cancer chemotherapy and pharmacology (2024)
Forrest L Baker, Kyle A Smith, Preteesh L Mylabathula, Tiffany M Zúñiga, Douglass M Diak, Helena Angelica Pereira Batatinha, Grace M Niemiro, Michael David Seckeler, Charles R Pedlar, Daniel P O'Connor, Jamie N Colombo, Emmanuel Katsanis, Richard J Simpson
Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition. Cancer research communications 4 (5) (2024)
Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Anant Vatsayan, Julie-An Talano, Christina Baggott, Deborah E Schiff, Emmanuel Katsanis, Arunkumar J Modi, Troy C Quigg, Sunil S Raikar, Liora M Schultz, Lauren Pommert
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood advances 8 (15) (2024)
Forrest L Baker, Kyle A Smith, Preteesh L Mylabathula, Tiffany M Zúñiga, Douglass M Diak, Helena Angelica Pereira Batatinha, Grace M Niemiro, Michael David Seckeler, Charles R Pedlar, Daniel P O'Connor, Jamie N Colombo, Emmanuel Katsanis, Richard J Simpson
Exercise-induced β2-adrenergic receptor activation enhances the anti-leukemic activity of expanded γδ T-Cells via DNAM-1 upregulation and PVR/Nectin-2 recognition. Cancer research communications (2024)
Forrest L Baker, Kyle A Smith, Preteesh L Mylabathula, Tiffany M Zúñiga, Douglass M Diak, Helena Angelica Pereira Batatinha, Grace M Niemiro, Michael David Seckeler, Charles R Pedlar, Daniel P O'Connor, Jamie N Colombo, Emmanuel Katsanis, Richard J Simpson
Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition. Cancer research communications 4 (5) (2024)
Megan J Cracchiolo, Lisa Davis, Andrew P Matiatos, Dan W Davini, Muhammad Husnain, Richard J Simpson, Vasilios Voudouris, Emmanuel Katsanis
Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies. Cancer chemotherapy and pharmacology (2024)
Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Anant Vatsayan, Julie-An Talano, Christina Baggott, Deborah E Schiff, Emmanuel Katsanis, Arunkumar J Modi, Troy C Quigg, Sunil S Raikar, Liora M Schultz, Lauren Pommert
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood advances (2024)
Kristy E Gilman, Andrew P Matiatos, Megan J Cracchiolo, Amanda G Moon, Dan W Davini, Richard J Simpson, Emmanuel Katsanis
Multiagent Intratumoral Immunotherapy Can Be Effective in A20 Lymphoma Clearance and Generation of Systemic T Cell Immunity. Cancers 15 (7) (2023)
Laurel Truscott, Holly Pariury, Santosh Hanmod, Monica Davini, Michelina de la Maza, Lauren N Sapp, Kyleigh Staples, Maria Proytcheva, Emmanuel Katsanis
Busulfan, fludarabine, and melphalan are effective conditioning for pediatric and young adult patients with myeloid malignancies underdoing matched sibling or alternative donor transplantation. Pediatric blood & cancer (2022)
Megan S Molina, Emely A Hoffman, Jessica Stokes, Nicole Kummet, Richard J Simpson, Emmanuel Katsanis
Murine precursors to type 1 conventional dendritic cells induce tumor cytotoxicity and exhibit activated PD-1/PD-L1 pathway. PloS one 17 (8) (2022)
Emmanuel Katsanis, Therese Hennig, Jacob E Robinson, Gwynn Long, Nelson J Chao, Mitchell E Horwitz, David Rizzieri
Revisiting a single day salvage conditioning following graft failure. Bone marrow transplantation 57 (12) (2022)
Holly Pariury, Laurel Truscott, Emmanuel Katsanis
Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease? Oncoimmunology 10 (1) (2021)
Akshay Sharma, Sujuan Huang, Ying Li, Russell John Brooke, Ibrahim Ahmed, Heather B Allewelt, Persis Jal Amrolia, Alice Bertaina, Neel S Bhatt, Marc B Bierings, Joshua Bies, Claire Brisset, Jennifer E Brondon, Ann Dahlberg, Jean-Hugues Dalle, Hesham Eissa, Mony Fahd, Adam Gassas, Nicholas J Gloude, W Scott Goebel, Erika S Goeckerman, Katherine Harris, Richard Ho, Michelle P Hudspeth, Jeffrey S Huo, David Jacobsohn, Kimberly A Kasow, Emmanuel Katsanis, Saara Kaviany, Amy K Keating, Nancy A Kernan, Yiouli P Ktena, Colette R Lauhan, Gerardo López-Hernandez, Paul L Martin, Kasiani C Myers, Swati Naik, Alberto Olaya-Vargas, Toshihiro Onishi, Mohamed Radhi, Shanti Ramachandran, Kristie Ramos, Hemalatha G Rangarajan, Philip A Roehrs, Megan E Sampson, Peter J Shaw, Jodi L Skiles, Katherine Somers, Heather J Symons, Marie de Tersant, Allison N Uber, Birgitta A B Versluys, Cheng Cheng, Brandon M Triplett
Outcomes of pediatric patients with therapy-related myeloid neoplasms. Bone marrow transplantation 56 (12) (2021)
Kelly Stanley, Santosh Hanmod, Richard J Simpson, Emmanuel Katsanis
Haploidentical hematopoietic cell transplantation is even more advantageous during the COVID-19 pandemic. Pediatric transplantation 25 (3) (2021)
Jessica Stokes, Emely A Hoffman, Megan S Molina, Nicole Kummet, Richard J Simpson, Yi Zeng, Emmanuel Katsanis
Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia. Oncoimmunology 9 (1) (2020)
Emmanuel Katsanis, Keri Maher, Denise J Roe, Richard J Simpson
Progressive substitution of posttransplant cyclophosphamide with bendamustine: A phase I study in haploidentical bone marrow transplantation. EJHaem 1 (1) (2020)
Marci Macaraeg, Maria Proytcheva, Emmanuel Katsanis
Transfusion independence after repeated haploidentical hematopoietic cell transplants in a patient with congenital dyserythropoietic anemia type II and hemosiderosis. Pediatric transplantation 23 (8) (2019)
Riley Graetz, Robyn Meyer, Kareem Shehab, Emmanuel Katsanis
Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection. Transplant infectious disease : an official journal of the Transplantation Society 20 (2) (2018)
Yi Zeng, Seongmin Hahn, Jessica Stokes, Emely A Hoffman, Monika Schmelz, Maria Proytcheva, Jonathan Chernoff, Emmanuel Katsanis
Pak2 regulates myeloid-derived suppressor cell development in mice. Blood advances 1 (22) (2017)
Abraham S Kanate, Alyssa DiGilio, Kwang W Ahn, Monzr Al Malki, Eric Jacobsen, Amir Steinberg, Nelson Hamerschlak, Mohamed A Kharfan-Dabaja, Rachel Salit, Edward Ball, Qaiser Bashir, Amanda Cashen, Daniel Couriel, Jose Diez-Martin, Emmanuel Katsanis, Yulia Linhares, Shahram Mori, Richard Nash, Attaphol Pawarode, Miguel-Angel Perales, Colin D Phipps, Carol Richman, Bipin N Savani, Michael Y Shapira, Patrick Stiff, Roger Strair, Timothy S Fenske, Sonali M Smith, Anna Sureda, Horatiu Olteanu, Mehdi Hamadani
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis. British journal of haematology 182 (6) (2017)
Onyemaechi N Okolo, Emmanuel Katsanis, Seongseok Yun, Candace Y Reveles, Faiz Anwar
Allogeneic Transplant in ELANE and MEFV Mutation Positive Severe Cyclic Neutropenia: Review of Prognostic Factors for Secondary Severe Events. Case reports in hematology 2017 (2017)
Y Zeng, J Stokes, S Hahn, E Hoffman, Emmanuel Katsanis
Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD. Bone marrow transplantation 49 (8) (2014)